Literature DB >> 9309304

Ethanol and natural killer cells. I. Activity and immunophenotype in alcoholic humans.

R T Cook1, F Li, D Vandersteen, Z K Ballas, B L Cook, D R LaBrecque.   

Abstract

The human lymphocyte fraction with the greatest fresh killing activity against K562 targets is phenotypically the CD3-CD19-CD56+ subset. There have been reports of reduced natural killer (NK) activity in human alcoholics, but overall consistency is lacking and phenotypic monitoring has been inadequate to allow reliable estimates of changes in the active cell fractions. We have evaluated a range of cell surface markers and fresh NK activity in controls and alcoholics, and now report abnormalities in both phenotype and function in some alcoholics, but a normal profile in others. Patients without evidence of active liver disease (AWLDs) tend to have normal fresh basal activities and phenotypic profiles. Patients with alcoholic liver disease (ALDs) have fewer Lin- lymphocytes that are CD56+. Three of 14 ALDs assayed in the present work had absent NK activity, whereas others were activated. In normal controls and in AWLDs, the presence of monocytes in the lytic assay consistently inhibits lysis; but, in some patients with ALD, the presence of monocytes is stimulatory to NK activity. In alcoholics as one group, there is a statistically significant relative increase in a novel Lin- subset of unknown function; this subset has a phenotype of Lin-CD56-CD45RO+.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9309304

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  12 in total

Review 1.  Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines.

Authors:  Andrew M Miller; Norio Horiguchi; Won-Il Jeong; Svetlana Radaeva; Bin Gao
Journal:  Alcohol Clin Exp Res       Date:  2011-02-01       Impact factor: 3.455

Review 2.  Interaction between alcohol and exercise: physiological and haematological implications.

Authors:  Mahmoud S El-Sayed; Nagia Ali; Zeinab El-Sayed Ali
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

3.  Lymphocyte measures in treatment-naïve 13-15-year old adolescents with alcohol use disorders.

Authors:  Celeste E Naude; Patrick Bouic; Marjanne Senekal; Martin Kidd; Helen L Ferrett; George Fein; Paul D Carey
Journal:  Alcohol       Date:  2011-05-31       Impact factor: 2.405

4.  A dynamic flux in natural killer cell subsets as a function of the duration of alcohol ingestion.

Authors:  Zuhair K Ballas; Robert T Cook; Michael R Shey; Ruth A Coleman
Journal:  Alcohol Clin Exp Res       Date:  2011-12-07       Impact factor: 3.455

Review 5.  Innate immunity in alcoholic liver disease.

Authors:  Bin Gao; Ekihiro Seki; David A Brenner; Scott Friedman; Jessica I Cohen; Laura Nagy; Gyongyi Szabo; Samir Zakhari
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-01-20       Impact factor: 4.052

6.  Chronic alcohol consumption inhibits peripheral NK cell development and maturation by decreasing the availability of IL-15.

Authors:  Faya Zhang; Alex Little; Hui Zhang
Journal:  J Leukoc Biol       Date:  2016-11-11       Impact factor: 4.962

Review 7.  Immunological aetiology of major psychiatric disorders: evidence and therapeutic implications.

Authors:  Barbara Sperner-Unterweger
Journal:  Drugs       Date:  2005       Impact factor: 9.546

8.  Chronic alcohol consumption exacerbates murine cytomegalovirus infection via impairing nonspecific and specific NK activation in mice.

Authors:  Alex Little; Yuanfei Li; Faya Zhang; Hui Zhang
Journal:  FASEB Bioadv       Date:  2018-09-14

9.  Roles of alcohol and tobacco exposure in the development of hepatocellular carcinoma.

Authors:  Vishnudutt Purohit; Rao Rapaka; Oh Sang Kwon; B J Song
Journal:  Life Sci       Date:  2012-10-30       Impact factor: 5.037

Review 10.  Focus on: Alcohol and the immune system.

Authors:  Patricia E Molina; Kyle I Happel; Ping Zhang; Jay K Kolls; Steve Nelson
Journal:  Alcohol Res Health       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.